• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Industry

  • Print
  • Share
  • E-mail

Webinar: Background on FDA and Patient-Focused Drug Development

Patient-Focused Drug Development is an initiative that involves obtaining a better understanding of patients’ perspectives on the severity of their disease and the available therapies for their condition. Patient-Focused Drug Development is being conducted to fulfill FDA performance commitments made as part of the authorization of the Prescription Drug User Fee Act under Title I of the Food and Drug Safety and Innovation Act (FDASIA) (Pub. L. 112–144).

The purpose of this webinar is to provide patient stakeholders with a background on the meetings under the Patient-Focused Drug Development initiative. This webinar is split into four modules, each focusing on a separate topic.
 

Webinar Modules